Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 10/20 | 0.49 |
| ▸ | CCKAR | P32238 | 8/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NOTCH1 | P46531 | 2/20 | 0.39 |
| ▸ | RBPJ | Q06330 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7006359 | 0.88 | CCKBR (0.37) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL7012796 | 0.82 | CCKBR (0.44) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL7005901 | 0.80 | CCKAR (0.44) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL7012788 | 0.76 | PSEN1 (0.37) | CCKBRCCKARMEN1KMT2A | |
| SCHEMBL7003908 | 0.74 | CCKBR (0.44) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL7011891 | 0.74 | CCKBR (0.44) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL7006763 | 0.74 | CCKBR (0.39) | CCKBRCCKAR | |
| SCHEMBL7009892 | 0.73 | CCKBR (0.43) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL7008743 | 0.72 | CCKAR (0.44) | CCKBRCCKARMEN1ALDH1A1KMT2A | |
| SCHEMBL7007597 | 0.72 | CCKBR (0.43) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1268450-A1 | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION | Bristol-Myers Squibb Pharma Company (US) | 2003-01-02 | — | — | EP | claimed |
| WO-2001092235-A1 | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-12-06 | — | — | WO | claimed |
| EP-1268450-A1 | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION | Bristol-Myers Squibb Pharma Company (US) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001092235-A1 | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-12-06 | — | — | WO | disclosed |